Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orbital-flop transition of superfluid <sup>3</sup>He in anisotropic silica aerogel.

Nature communications·2024
Same author

Magnetic Susceptibility of Andreev Bound States in Superfluid ^{3}He-B.

Physical review letters·2023
Same author

Greener residential environment is associated with increased bacterial diversity in outdoor ambient air.

The Science of the total environment·2023
Same author

Embolism of the Pulmonary Artery in a Horse.

The Journal of comparative medicine and veterinary archives·2022
Same author

Effect of Magnetic Impurities on Superfluid ^{3}He.

Physical review letters·2020
Same author

Non-technical skills of surgeons and anaesthetists in simulated operating theatre crises.

The British journal of surgery·2017

Related Experiment Video

Updated: Jun 25, 2026

A High-content Assay for Monitoring AMPA Receptor Trafficking
10:34

A High-content Assay for Monitoring AMPA Receptor Trafficking

Published on: January 28, 2019

Structure and function of AMP-activated protein kinase.

J S Oakhill1, J W Scott, B E Kemp

  • 1St Vincent's Institute and Department of Medicine University of Melbourne, Fitzroy, Victoria, Australia.

Acta Physiologica (Oxford, England)
|February 28, 2009
PubMed
Summary

AMP-activated protein kinase (AMPK) controls cellular energy balance. Structural insights reveal its architecture and AMP binding sites, aiding the development of new activators like A769662 and PTI.

More Related Videos

Amide Hydrogen/Deuterium Exchange &amp; MALDI-TOF Mass Spectrometry Analysis of Pak2 Activation
07:15

Amide Hydrogen/Deuterium Exchange & MALDI-TOF Mass Spectrometry Analysis of Pak2 Activation

Published on: November 26, 2011

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy
10:41

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy

Published on: June 7, 2019

Related Experiment Videos

Last Updated: Jun 25, 2026

A High-content Assay for Monitoring AMPA Receptor Trafficking
10:34

A High-content Assay for Monitoring AMPA Receptor Trafficking

Published on: January 28, 2019

Amide Hydrogen/Deuterium Exchange &amp; MALDI-TOF Mass Spectrometry Analysis of Pak2 Activation
07:15

Amide Hydrogen/Deuterium Exchange & MALDI-TOF Mass Spectrometry Analysis of Pak2 Activation

Published on: November 26, 2011

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy
10:41

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy

Published on: June 7, 2019

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Metabolic Regulation

Background:

  • AMP-activated protein kinase (AMPK) is a critical regulator of cellular energy homeostasis.
  • AMPK activation occurs via increased intracellular AMP or calcium signaling, leading to substrate phosphorylation.
  • Recent structural studies elucidate subunit interactions and AMP binding sites within AMPK.

Purpose of the Study:

  • To detail the structural architecture of AMPK subunit interactions.
  • To characterize the AMP binding pockets on the gamma subunit.
  • To understand the autoinhibition mechanism of the alpha catalytic domain.

Main Methods:

  • Structural biology techniques to reveal subunit interactions.
  • Homology modeling based on MARK2 protein structure to propose inhibitory interactions.
  • Pharmacological studies of direct AMPK activators.

Main Results:

  • The study reveals the structural basis of alphabetagamma subunit interactions in AMPK.
  • AMP binding pockets on the gamma subunit are identified.
  • A C-terminal tail (313-335) is proposed to autoinhibit the alpha catalytic domain (1-280).
  • Two direct AMPK activators, A769662 and PTI, were identified, potentially acting via distinct mechanisms.

Conclusions:

  • Structural understanding of AMPK provides a basis for targeted drug development.
  • The identified activators, A769662 and PTI, offer new therapeutic avenues for metabolic disorders.
  • Further research into the distinct activation mechanisms of these drugs is warranted.